BERNARDS RENE purchased 8.0% of their position (10K shares) of LIXTE BIOTECHNOLOGY HOLDINGS, INC. on the open market
Open‑market purchase worth $6.1K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/13/2022ACC: 0001493152-22-035280
Director
Since Jun 2022
+10K
Net shares
Net buyer
$6.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$0.61
Trade value
$6.10K
% of position
8.0%
12/12/2022
125K→135K
Total
Net shares
+10K
Net value
$6.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/12/2022 | P · Purchase | +10K | $0.61 | $6.10K | 8.0% | 125K | 135K |
| Total | +10K | $6.10K | ||||||
Derivative Transactions0
No derivative transactions reported